Adherence: A review of education, research, practice and policy in Switzerland

Pharmacy Practice

Volumn 7, Issue 2, 2009, Pages 63-73

  Schneider, Marie P ^a   Krummenacher, Isabelle ^b   Figueiredo, Hugo ^b   Marquis, Julien ^b   Bugnon, Oliver ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Medication Adherence; Pharmacists; Switzerland

Indexed keywords

CLINICAL PRACTICE; COGNITION; FEASIBILITY STUDY; HEALTH CARE POLICY; HEALTH INSURANCE; HEALTH PROGRAM; MEDICAL EDUCATION; MEDICAL INFORMATION; MEDICAL RESEARCH; PHARMACEUTICAL CARE; PHARMACIST; PHARMACY; PRACTICE GUIDELINE; REVIEW; SWITZERLAND;

EID: 70349204641     PISSN: None     EISSN: 18863655     Source Type: Journal    
DOI: 10.4321/S1886-36552009000200001     Document Type: Review

References (36)

1. Glass TR, De Geest S, Hirschel B, Battegay M, Furrer H, Covassini M, Vernazza PL, Bernasconi E, Rickenboch M, Weber R, Bucher HC; Swiss HIV Cohort Study. Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in-virologically suppressed patients. Antivir Ther 2008;13(1):77-85.
2. World Health Organization. Adherence to long-term therapies. Evidence for action. Report of World Health Organization, 2003.
3. NICE recommendation on medication adherence: http://www.nice.org.uk/CG76 (accessed 12-5-2009).
4. Pharmacy School, University of Geneva. http://www.unige.ch/scinces/pharm/ f/fla↘ction/edito.php (accessed 28-05-2009).
5. pharmActuei program: http://www.pharmasuisse.org/fr/ pharmazie_fachpublikum/04_publikationen/ pharmactuel.php?navanchor=1010013 (accessed 12-5-2009).
6. CAP Association of community pharmacists: http://cours.pharmacap.ch/ calendrier/calendrier.asp?lang=fr (accessed 12-5-2009).
7. Diploma in therapeutic education, University of Geneva: http://www.unige.ch/formcort/difep.htmi (accessed 12-5-2009).
8. Krummenacher I, Cavassini M, Bugnon O, Spirig R, Schneider MP. Antiretroviral Adherence-Enhancing Management Program in HIV patients: A Feasibility Study in the Swiss HIV Cohort Study (sent for publication).
9. Santschi V, Rodondi N, Bugnon O, Burnier M. Impact of electronic monitoring of drug adherence on blood pressure control in primary care: A cluster 12-month randomised controlled study. Eur J Intern Med 2008;19(6):427-434.
10. Amet I, Schoenenberger RA, Spiegel R, Haefeli WE. [Conviction as a basis for compliance and strategies for improving compliance]. Schweiz Med Wochenschr. 1999;129(41):1477-1486.
11. Bertholet N, Favrat B, Fallab-Stubi CL, Brunner HR, Burnier M. Why Objective Monitoring of Compliance is Important in the Management of Hypertension. J Clin Hypertens (Greenwich). 2000;2(4):258-262.
12. Burnier M, Schneider MP, Chiolero A, Stubi CL, Brunner HR. Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens. 2001;19(2):335-341.
13. Fallab-Stubi CL, Zellweger JP, Sauty A, Uldry C, Iorillo D, Burnier M. Electronic monitoring of adherence to treatment in the preventive chemotherapy of tuberculosis. Int J Tuberc Lung Dis. 1998;2(7):525-530.
14. Landry P, Iorillo D, Darioli R, Burnier M, Genton B. Do travelers really take their mefloquine malaria chemoprpphylaxis? Estimation of adherence by an electronic pillbox. J Travel Med. 2006;13(1):8-14.
15. Schneider MP, van Melle G, Uldry C, Huynh-Ba M, Fallab Stubi CL, Iorillo D, Burnier M, Zellweger JP.Electronic monitoring of long-term use of the nicotine nasal spray and predictors of success in a smoking cessation program. Nicotine Tob Res 2003;5(5):719-727.
16. Schwed A, Fallab CL, Burnier M, Waeber B, Kappenberger L, Burnand B, Darioli R. Electronic monitoring of compliance to lipid-lowering therapy in clinical practice. J Clin Pharmacol. 1999;39(4):402-409.
17. Stubi CL, Landry PR, Petignat C, Bille J, Genton B, Darioli R et al. Compliance to live oral Ty21a typhoid vaccine, and its effect on viability. J Travel Med. 2000;7(3):133-137.
18. Wermeille J, Cunningham M, Dederding JP, Girard L, Baumann R, Zelger G, Buri P, Metry JM, Sitavanc R, Gallaz L, Merki H, Godin N. Failure of Helicobacter pylori eradication: is poor compliance the main cause? Gastroenterol Clin Biol. 2002;26(3):216-219.
19. Amet I, Haefeli WE. Overconsumption detected by electronic drug monitoring requires subtle interpretation. Clin Pharmacol Ther. 2000;67(1):44-47.
20. Santschi V, Wuerzner G, Schneider MP, Bugnon O, Burnier M. Clinical evaluation of IDAS II, a new electronic device enabling drug adherence monitoring. Eur J Clin Pharmacol. 2007;63(12):1179-1184.
21. Schneider MP, Burnier M. On-line home monitoring of drug compliance: is it feasible? Eur J Clin Pharmacol. 1998;54(6):489-490.
22. Figueiredo H, Tousset E, Burnier M, Vrijens B, Bugnon O, Schneider MP. Medication adherence over time, and association between quality of execution and systolic blood pressure in resistant hypertension (in preparation).
23. Schneider MP, Despland PA, Buclin Th, Burnier M. Evaluation of online telemonitoring of drug adherence: a pilot randomized, controlled study in patients with epilepsy. J Inform Technol Healthcare. 2003;1(6):419-435.
24. Miller WR, Rollnick S, Conforti K. Motivational Interviewing: Preparing People for Change (2nd edition). The Guilford Press ed. 2002.
25. Cooperman NA, Amsten JH. Motivational interviewing for improving adhererce to antiretroviral medications. Curr HIV/AIDS Rep. 2005;2(4):159-164.
26. Adamian MS, Golin CE, Shain LS, DeVellis B. Brief motivational interviewing to improve adherence to antiretroviral therapy: development and qualitative pilot assessment of an intervention. AIDS Patient Care STDS. 2004;18(4):229-238.
27. Fisher JD, Fisher WA, Amico KR, Harman JJ. An information-motivation-behavioral skills model of adherence to antiretroviral therapy. Health Psychol. 2006;25(4):462-473.
28. Fisher JD, Amico KR, Fisher WA, Harman JJ. The information-motivation-behavioral skills model of antiretroviral adherence and its applications. Curr HIV/AIDS Rep. 2008;5(4):193-203.
29. Bandura a. Health functioning. In: Bandura a, editor. Self-efficacy, the exercice of control. New York: W.H. Freeman and Co; 1997. 259-318.
30. Munro SA, Lewin SA, Swart T, Volmink J. A review of health behaviour theories: how useful are these for developing interventions to promote long-term medication adherence for TB and HIV/AIDS? BMC Public Health. 2007;7(1):104.
31. Waeber B, Burnier M, Brunner HR. Compliance with antihypertensive therapy. Clin Exp Hypertens. 1999;21(5-6):973-985.
32. Denhaerynck K, Schafer-Keller P, Young J, Steiger J, Bock A, De GS. Examining assumptions regarding valid electronic monitoring of medication therapy: development of a validation framework and its application on a European sample of kidney transplant patients. BMC. Med Res Methodol 2008; 8:5.
33. Weber R, Christen L, Christen S, Tschopp S, Znoj K. Schneider C et al. Effect of individual cognitive behaviour intervention on adherence to antiretroviral therapy: prospective randomized trial. Antivir Ther 2004;9(1):85-95.
34. Lamiraud K, Moatti JP. Economic implications of nonadherence to highly active antiretroviral treatment in HIV patients. Expert Opin Pharmacother 2006;7(2):135-143.
35. Guignard E, Bugnon O. Pharmaceutical care in community pharmacies: practice and research in Switzerland. Ann Pharmacother 2006;40(3):512-517.
36. Haas C. RBPIV: Convention envoyée au Conseil fédéral pour approbation. pharmaJournal 2009;(08):20.